Dr. James Bryan Parmele, MD

Dr. Parmele practices at Metropolitan Surgical Center in Maple Grove, Minnesota.

Dr. Parmele's NPI, 1255545687, was assigned on May 8, 2007. Dr. Parmele graduated from University of Kansas School of Med (KC/Wich/Sal) in 2002. Dr. Parmele holds Minnesota license 49587.

Dr. Parmele's primary practice is Metropolitan Surgical Center, at 9645 Grove Circle North Suite 250, Maple Grove, MN 55369. The practice phone is (763) 201-8191.

Dr. Parmele's primary practice is Metropolitan Surgical Center in Maple Grove, Minnesota. The medical group on file is iSpine Clinics. Dmand AI also links Dr. Parmele to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Parmele practices, 2 sites in all. Vendor and product names are available with a free account.

Interventional pain medicine is Dr. Parmele's primary specialty in the NPI Registry, under taxonomy code 208VP0014X. Dr. Parmele is licensed in Minnesota.

CMS data shows 2,943 Medicare services from Dr. Parmele across 30 procedure codes in 2024, for 578 Medicare patients. Medicare paid $123,529 for them.

CMS counts 578 Medicare patients who saw Dr. Parmele in 2024. The largest group is 65 to 74, with 236 patients. 75% of them have arthritis, and 65% have high blood pressure. 26% are also on Medicaid. Their average risk score is 1.49, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Parmele's median patient age at 62, with 62% women.

In 2024, Dr. Parmele wrote 725 Medicare Part D claims for 230 patients. 97% of them were for generic drugs. CMS names the drug for 640 of them, across 14 drugs with 11 or more claims each, at $7,862 in total drug cost. In 2023, CMS named 612 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Parmele for performance year 2024, reported individually. Dr. Parmele accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Parmele, published from 2021 to 2022. 2021 was the busiest year, with 2. Dr. Parmele's most frequent co-authors are Ryan D'Souza, DO, Jonathan Michael Hagedorn, MD and Jason Sanford Wolff, MD.

CMS Open Payments shows 295 general payments to Dr. Parmele from 29 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 67% of the total. Medtronic USA, Inc. paid the most, $7,509. It also lists 3 research payments totaling $2,645 in 2022.

Dr. Parmele graduated from University of Kansas School of Med (KC/Wich/Sal) in 2002.